J|I Japan Investor Interface · Compounder Profile
TSE PRIME · 2733 · FY end Mar 株式会社あらた

ARATA Corporation

Japan's #2 wholesaler of daily necessities, cosmetics and pet supplies — the middle layer linking makers to retailers
Last Close
¥2,570Jul 16, 2026
−30% from Sep-24 peak · +8% off the Jun-26 low
Market Cap / EV
¥86.0bn / ¥95.3bn EV
net debt ¥9.2bn (11% of cap) · 33.5M sh ex-treasury
EV / OP · forward
8.7x
on FY03/27 OP ¥11.0bn · 7.2x trailing · core 7.4x
ROCE · trailing
8.2%
down from 10.4% → 10.0% · ROE 8.4%
OP Margin · group
1.3% · grp
FY03/27 guide 1.1% · ~9.7% gross margin
Shares & Float
33.5M sh · foreign ~22%
no controlling parent · Fidelity value fund 3.29%
INTRODUCTION

What does ARATA do?

ARATA is Japan's second-largest wholesaler of daily necessities, cosmetics, household goods and pet supplies, behind PALTAC. It is the middle layer of distribution: it buys from about 1,100 manufacturers and delivers to roughly 3,370 retailers across the country. Drugstores, home centers and supermarkets are its main customers. ARATA runs as a single business, formed in 2002 by combining three regional wholesalers and expanded since by acquiring more.

ARATA earns a spread. It buys goods in bulk, stores them, delivers them daily through its own temperature-controlled network, and helps stores plan what goes on the shelf. Gross margin is only about 9.7% and OP margin about 1.3%, so it makes a little money on very large volume. Its extra value is data: ARATA analyzes point-of-sale records to design shelf plans, and it carries a growing book of exclusive lines that rivals cannot stock, about 7.8% of sales.

The company grows in three ways. It consolidates a fragmenting wholesale industry by buying smaller rivals. It deepens its data edge — in December 2025 it joined the True Data alliance, a shared purchase-record pool covering about 60 million people. And it has moved upstream: in January 2026 it bought msh, the maker of the Love Liner cosmetics brand, so it now owns product rather than only carrying it.

FY03/26 was the year ARATA crossed ¥1trn of revenue, at ¥1,004.7bn, a 4.1% annual growth rate over three years. But OP fell 11.9% YoY to ¥13.2bn, and the company guides FY03/27 lower still, to ¥11.0bn — it calls FY03/27 the bottom. ROCE has slipped from 10.4% to 8.2% over three years as the margin thinned. ARATA also carries ¥9.2bn of net debt, the only distributor among its peers not in a net-cash position, and its shares trade at 0.69x book value.

For an investor the question is whether this is the low point. ARATA earns a 1.3% margin. Its shares trade below book value and at 8.7x forward EV/OP. That is cheap if profit recovers from here. It is a poor buy if ARATA’s retail customers keep taking a larger share of the margin each year.

01 · PRICE REGIME

What has driven the stock over the past two years?

The revenue milestone could not offset a structurally thin margin.

2733 vs TOPIX · 24 months · daily candles + volume
Peak ¥3,685 · 2024-09-10 Trough ¥2,382 · 2026-06-22 Today ¥2,570
ARATA · daily candles 60-day SMA TOPIX rebased (index) Volume

01 · When investors paid up for the ¥1-trillion story ARATA rose to a post-split high of ¥3,685 on September 10, 2024. The 2:1 split that January had widened the float and lowered the entry price, and investors bought the company's approach to ¥1trn of revenue and its record of rolling up smaller wholesalers. Demand for daily necessities looked steady and hard to disrupt. At the peak, EV/OP was roughly 9x on the guidance then in force.

02 · When the thin margin came into focus Through 2025 ARATA kept growing sales, but its costs grew faster. Warehouse spending and freight rose, and so did the center fees† that retailers charge ARATA for moving goods through the retailers’ own distribution centers. OP margin drifted down to about 1.3%. Investors came to see 1.3% as the level this business would keep earning, because ARATA has little room to raise its prices against big retail customers, and the shares fell through the year.

03 · The February 2026 guidance cut On February 10, 2026, after the close, ARATA cut its FY03/26 OP guidance by 17.6%. Coming after two years of falling margin, the cut told investors the higher costs were likely here to stay. Investors kept selling, and the de-rating continued into the spring.

04 · Where the stock stands now ARATA reported FY03/26 results on May 14 — revenue past ¥1trn but OP down 11.9% YoY — and guided FY03/27 as an earnings trough alongside its 2030 medium-term plan. The slide bottomed at ¥2,382 on June 22, 2026, then recovered to ¥2,570 by July 16. Over 24 months ARATA fell 26.6% while the TOPIX index rose 47.0%, one of the worst showings against the market. Whether that gap is deserved depends on whether ARATA’s profit recovers or stays near this low level.

† NOTE · WHAT A “CENTER FEE” IS A center fee is a charge a large retailer bills its suppliers for using the retailer’s own distribution center. It works like this. ARATA used to deliver goods to each individual store. As retail chains grew, they built their own central warehouses, and now ARATA delivers there in bulk instead; the retailer then carries the goods the last leg out to its own stores. Because the retailer does that final delivery, it charges ARATA a fee for it — usually a set percentage of the value of the goods passing through. That fee comes straight out of ARATA’s roughly 1.3% OP margin, so when a retailer raises it, ARATA keeps less on each sale. As drugstore and supermarket chains merge into bigger groups, they gain more room to raise these fees.
02 · CONTENTION

What investors disagree about

Scale, margin recovery, and acquisition returns determine what ARATA is worth.

DEBATE 01 · DISINTERMEDIATION
Can a 1.3%-margin wholesaler stay indispensable as retail consolidates?

ARATA sits between about 1,100 makers and 3,370 retailers, buying in bulk, warehousing, and delivering daily on a spread of roughly 1.3%. As drugstore and supermarket chains merge, they gain the scale to run logistics themselves. What matters is whether ARATA's network stays cheaper than doing it in-house.

BULL
  • ARATA combines scale, retail data, and a national temperature-controlled network that few retailers can rebuild.
  • ARATA is the second-largest of only a few national wholesalers, so when two retailers merge, the combined chain still orders through ARATA and more goods pass through its warehouses.
  • Its point-of-sale shelf plans and exclusive lines add service a plain logistics contract cannot.
BEAR
  • Big retailers such as Tsuruha, now inside the Welcia and Aeon group, can build their own delivery and charge ARATA a fee to use it.
  • On a 1.3% margin ARATA cannot absorb a higher fee without losing money.
  • Separately, some makers now sell straight to large retailers, cutting ARATA out of those orders.
DEBATE 02 · MARGIN
Is the profit fall a cyclical squeeze or a permanent step-down?

In FY03/26 ARATA's sales rose 1.9% YoY but its overheads rose 3.6% and freight 5.1%, so OP fell and margin slipped to 1.3%. FY03/27 guidance puts it at 1.1%. What matters is whether inflation and one-off costs caused this, or whether retail buyer-power has set a lower ceiling.

BULL
  • The squeeze looks temporary. A Hiroshima logistics-center move and acquisition fees weighed on FY03/26, while a richer mix of cosmetics and exclusive products should carry higher margins. Management is also spending before the expected recovery.
BEAR
  • The pressure may be structural. Sales grew 1.9%, but overhead grew 3.6% and freight 5.1%, continuing a two-year pattern. ARATA has not yet shown that it can make its largest customers absorb those higher costs.
DEBATE 03 · THE UPSTREAM BET
Does buying cosmetics brands earn ARATA's ¥8.6bn of goodwill?

In January 2026 ARATA bought msh, maker of the Love Liner eye-makeup brand, adding about ¥8.6bn of goodwill. A distributor was buying a brand it used only to carry. What matters is whether owning the product captures the maker's margin, or stretches ARATA outside what it does well.

BULL
  • ARATA already reaches roughly 3,370 retailers, so it can put Love Liner, Polite, and D-Nee on more shelves than msh could alone and capture the maker's margin alongside the distribution spread.
  • Cosmetics carry a higher gross margin than daily necessities and deepen ARATA's category-data edge.
BEAR
  • ARATA paid ¥8.6bn of goodwill plus integration cost with no disclosed return hurdle for the deal.
  • Owning and marketing a brand is a different skill from moving other makers' boxes, and a wholesaler's buyers may not run a cosmetics label well.
  • The purchase lands while the margin is already falling.
03 · INFLECTIONS

What is changing in who owns it, who buys from it, and the edge?

OWNERSHIP
Who owns ARATA, and is the register moving?
2024-01 · STOCK SPLIT
  • The 2:1 split in January 2024 widened the float and lowered the entry price, opening the register to more investors.
  • ARATA has no controlling parent; its largest holder is a passive trust bank at 11.6%.
STANDING · A VALUE HOLDER INSIDE
  • Foreign ownership runs near 22%, and it includes Fidelity Low-Priced Stock at 3.29% — a value fund already holding a stock at 0.69x book.
  • The supplier Lion holds 2.79% as a cross-holder.
RELATIONSHIPS
Who buys, and are the relationships holding?
FY03/26 · CHANNEL CONCENTRATION
  • The drugstore channel is 52% of sales and rising, and Tsuruha is the only account above 10%, at 13.6%.
  • The book is concentrated in the fastest-growing retail format.
2025 → · BUYER POWER RISING
  • Tsuruha is folding into the Welcia and Aeon orbit, which raises the buyer power of ARATA's single largest account.
  • A bigger customer can press harder on price and on center fees.
EDGE / OBSOLESCENCE
Is the edge strengthening, or being overtaken?
2025-12-18 · DATA EDGE
  • ARATA joined the True Data alliance, a shared purchase-record pool covering about 60 million people, deepening the category data behind its shelf plans.
  • Better data makes its store-front marketing harder to replace.
2026-01 · PRODUCT EDGE
  • The msh acquisition moved ARATA upstream into owning the Love Liner cosmetics brand, adding higher-margin product to a thin-spread book.
04 · CATALYST

Disclosure & Capital Levers

The next disclosures can show whether today's trough valuation is justified.

LEVER 01 · GUIDANCE
Show FY03/27 is the trough and that margin inflects up toward the 2030 plan
The guided trough and the 2030 targets (¥bn)
FY03/26 OP
¥13.2bn
FY03/27 OP (trough)
¥11.0bn
FY03/30 recurring-profit target
¥16.0bn
FY03/30 EBITDA target
¥24.0bn
FY03/27 is the guided low; the 2030 plan spends cost up front for a higher margin later
  • ARATA guides FY03/27 as the bottom, with OP of ¥11.0bn, because the medium-term plan spends on growth and integration first. A later margin recovery would show that those costs were temporary.
What it takes
Growth capex + msh integration
When it could happen
FY03/28 results · from Aug 2027
LEVER 02 · CAPITAL RETURNS
Unwind policy cross-holdings and fund a buyback to attack the sub-book price
The levers against a 0.69x P/B
Cash & deposits
¥39.7bn
Policy cross-holdings (fair value)
¥13.6bn
Dividend yield
4.4%
Payout ratio (FY03/27 guide)
53.5%
¥13.6bn of cross-holdings plus rising cash are the raw material for a return that lifts a sub-book stock
  • Management has newly named ROIC as its discipline. A FY03/27 buyback or a disclosed reduction in policy shareholdings would put that discipline into practice.
What it takes
Board resolution + cash
When it could happen
Cross-holding cut · FY03/27
LEVER 03 · GROWTH
Scale Love Liner and private brands through ARATA's 3,370-retailer reach
A thin spread, and the mix lever on it (%)
Group gross margin (FY03/26)
~9.7%
Exclusive / priority lines · of sales
~7.8%
Group OP margin
1.3%
the exclusive-line and owned-brand mix is the main lever on a ~9.7% gross margin
  • ARATA's gross margin is only about 9.7% and its OP margin 1.3%, so a richer product mix is the main lever it controls.
  • Owning msh (Love Liner, the top-selling eye-liner) and Polite, alongside its own D-Nee brand, lets ARATA sell higher-margin cosmetics through roughly 3,370 retailers rather than only carrying others'.
What it takes
Already-owned brands + shelf
When it could happen
Mix commentary · FY03/27–28
05 · VALUATION

Scenario Pathways

The cases start from ¥2,570 and FY03/27 OP guidance.

BEAR SCENARIO
¥2,100 – ¥2,300
−18% to −11%
implied multiple · ~6.5x EV/OP on ¥11.0bn trough OP
The margin squeeze proves structural, not cyclical. Retail buyer-power and center fees keep OP margin at or below the guided 1.1%, the 2030 recovery does not arrive, and OP sits near the ¥11.0bn trough with no re-rating.

Even here the ¥112 dividend yields 4.4% at the current price, and the payout has risen eleven years running.

BASE SCENARIO
¥2,950 – ¥3,150
+15% to +23%
implied multiple · ~7.8x EV/OP on ¥13.0bn mid-cycle OP
Cost discipline and a richer mix restore OP toward the FY03/26 ¥13bn level. Slower overhead growth, the msh cosmetics mix and exclusive lines rebuild the margin, and the multiple holds mid-pack among distributors.
BULL SCENARIO
¥3,400 – ¥3,636
+32% to +42%
implied multiple · ~8.5x EV/OP on ¥14.0bn OP
The 2030 plan gains traction and capital policy turns. Recurring profit heads toward ¥16bn, a cross-holding unwind funds a buyback that defends the sub-book price, OP runs to ¥14bn, and ARATA re-rates partway toward PALTAC.

The top of the range, ¥3,636, sits below the September 2024 peak of ¥3,685 — reclaiming the record would need the FY03/27 trough clearly behind the company.

SUM-OF-PARTS · OPERATING BUSINESS
One nationwide wholesale business — buy, warehouse, deliver, and market at the shelf
FY03/26 OP¥13,207M
FY03/26 revenue · growth¥1,004,700M · +1.9%
Group OP margin1.3% (FY03/27 guide 1.1%)
FY03/27 OP guidance (trough)¥11,000M
Assumed EV / OP6.5–8.5x
Implied operating EV ~¥71.5–119.0bn across the 6.5–8.5x band; the discount to PALTAC's 12.0x reflects the thinner margin and net debt.
SUM-OF-PARTS · SECURITIES & NET DEBT
Policy cross-holdings, net of embedded tax, against the borrowings that fund the network
Policy investment securities (fair value)¥13,603M
− Deferred tax on embedded gain~¥1,670M
= Securities net of tax~¥11,933M
Cash & deposits − interest-bearing debt¥39.7bn − ¥48.9bn
= Net debt (2026-03-31)¥9,218M
Lease liabilities of ¥4.8bn are excluded from debt. The securities are marked to the July 16 close and valued net of the tax on their embedded gain.
PEER MULTIPLE LADDER · EV / OP
Listed Japanese distributors (live July 16 prices; forward where guided, PALTAC trailing)
Kato Sangyo (9869)~7.1x
Suzuken (9987)~7.3x
ARATA (2733)~8.7x
PALTAC (8283)~12.0x
Snapshot July 16, 2026; each on its own OP at the latest close. ARATA's discount to PALTAC reflects its thinner margin and net debt.
PEER MULTIPLE LADDER · what each peer does
Why the comparison is fair, and where it is not
PALTAC (8283)#1 rival · net cash ¥83bn
Suzuken (9987)pharmaceutical distribution
Kato Sangyo (9869)food distribution
Sector move (2025)Mitsubishi Shokuhin taken private
PALTAC is the direct rival, at a 2.1% margin and net cash; the food and pharma distributors run near 1.5%. Mitsubishi Shokuhin's 2025 take-private shows the sector consolidating.
EQUITY BRIDGE · implied value per share
Operating EV plus securities, minus net debt, over ex-treasury shares
Operating EV (6.5–8.5x EV/OP)¥71.5–119.0bn
+ Securities net of tax¥11.9bn
− Net debt¥9.2bn
= Implied equity value¥74.2–121.7bn
÷ ex-treasury shares33,476,712
= Implied value per share¥2,217–3,636
vs ¥2,570 close−14% to +42%
Our mid-case is about ¥3,110, roughly 21% above the current price. The market is valuing a trough multiple on a trough year.
Important Disclaimer · 重要なご注意

This is not investment advice.

Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.

JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion.

No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.

No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.

Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.

Conflicts of interest. JII, its officers, and related parties do not hold or trade securities of companies covered in JII research. If JII has a paid engagement with a company covered in a publication, that relationship is disclosed in the relevant publication. JII's publications are for informational purposes only and do not constitute investment advice or a recommendation to buy or sell any security.

本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII(株式会社ジャパン・インベスター・インターフェース)は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。

All Compounder Profiles · Methodology Language: EN · JP